Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Sapporo Drug Store Co Ltd (2786)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Sapporo Drug Store historical data, for real-time data please try another search
2,035.0 0.0    0.00%
09/08 - Closed. Currency in JPY ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 2,027.0 / 2,036.0
  • Day's Range: 1,990.0 - 2,052.0
Type:  Equity
Market:  Japan
ISIN:  JP3320600004 
Sapporo Drug Store 2,035.0 0.0 0.00%

TYO:2786 Financials

 
This summary provides an overview of the most significant critical numbers from each of the Sapporo Drug Store Co Ltd financial reports, including theSapporo Drug Store income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the TYO:2786 financials over time via breakdowns of their annual reports.

For the three months ended 15 May 2016, SAPPORO DRUG STORE CO., LTD. revenues increased 22% to Y16.11B. Net income applicable to common stockholders increased from Y35M to Y147M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from NOP Interest expenses decrease of 15% to Y22M (expense).

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

2786 Income Statement & Profits

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: May 15, 2016 Feb 15, 2016 Nov 15, 2015 Aug 15, 2015
Total Revenue 16107 17110 16148 16336
Gross Profit 3841 4156 3801 3901
Operating Income 250 177 248 431
Net Income 147 75 150 259

2786 Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: May 15, 2016 Feb 15, 2016 Nov 15, 2015 Aug 15, 2015
Total Assets 29915 29012 28849 28589
Total Liabilities 22130 21254 23072 22963
Total Equity 7785 7758 5777 5626

%ENGLISH_NAME% Latest Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: May 15, 2016 Feb 15, 2016 Nov 15, 2015 Aug 15, 2015
Period Length: 0 Months 12 Months 0 Months 6 Months
Cash From Operating Activities 5 1479
Cash From Investing Activities -1272 -653
Cash From Financing Activities 2483 -220
Net Change in Cash 1216 606
* In Millions of JPY (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

2786 Price Commentary

Write your thoughts about Sapporo Drug Store Co Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email